Grand Pharmaceutical Group Limited (HK:0512)
:0512
Want to see HK:0512 full AI Analyst Report?
Total Valuation
Grand Pharmaceutical Group Limited has a market cap or net worth of HK$21.83B. The enterprise value is HK$25.09B.
Market CapHK$21.83B
Enterprise ValueHK$25.09B
Share Statistics
Grand Pharmaceutical Group Limited has 3,549,571,000 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding3,549,571,000
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Grand Pharmaceutical Group Limited’s return on equity (ROE) is 0.07 and return on invested capital (ROIC) is 5.67%.
Return on Equity (ROE)0.07
Return on Assets (ROA)0.05
Return on Invested Capital (ROIC)5.67%
Return on Capital Employed (ROCE)0.08
Revenue Per Employee1.02M
Profits Per Employee103.52K
Employee Count11,987
Asset Turnover0.45
Inventory Turnover3.71
Valuation Ratios
The current PE Ratio of Grand Pharmaceutical Group Limited is 95.7. Grand Pharmaceutical Group Limited’s PEG ratio is -0.44.
PE Ratio95.7
PS Ratio2.24
PB Ratio1.62
Price to Fair Value1.62
Price to FCF35.50
Price to Operating Cash Flow13.68
PEG Ratio-0.44
Income Statement
In the last 12 months, Grand Pharmaceutical Group Limited had revenue of 12.28B and earned 1.24B in profits. Earnings per share was 0.35.
Revenue12.28B
Gross Profit6.78B
Operating Income1.55B
Pretax Income1.49B
Net Income1.24B
EBITDA2.13B
Earnings Per Share (EPS)0.35
Cash Flow
In the last 12 months, operating cash flow was 1.58B and capital expenditures -726.15M, giving a free cash flow of 849.34M billion.
Operating Cash Flow1.58B
Free Cash Flow849.34M
Free Cash Flow per Share0.24
Dividends & Yields
Grand Pharmaceutical Group Limited pays an annual dividend of HK$0.26, resulting in a dividend yield of 3.13%
Dividend Per ShareHK$0.26
Dividend Yield3.13%
Payout Ratio43.77%
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.72
52-Week Price Change-26.08%
50-Day Moving Average7.28
200-Day Moving Average8.23
Relative Strength Index (RSI)42.58
Average Volume (3m)9.26M
Important Dates
Grand Pharmaceutical Group Limited upcoming earnings date is Aug 12, 2026, TBA (Confirmed).
Last Earnings DateMar 26, 2026
Next Earnings DateAug 12, 2026
Ex-Dividend Date―
Financial Position
Grand Pharmaceutical Group Limited as a current ratio of 1.14, with Debt / Equity ratio of 27.75%
Current Ratio1.14
Quick Ratio0.93
Debt to Market Cap0.17
Net Debt to EBITDA1.67
Interest Coverage Ratio9.52
Taxes
In the past 12 months, Grand Pharmaceutical Group Limited has paid 249.78M in taxes.
Income Tax249.78M
Effective Tax Rate0.17
Enterprise Valuation
Grand Pharmaceutical Group Limited EV to EBITDA ratio is 14.59, with an EV/FCF ratio of 40.09.
EV to Sales2.53
EV to EBITDA14.59
EV to Free Cash Flow40.09
EV to Operating Cash Flow20.69
Balance Sheet
Grand Pharmaceutical Group Limited has HK$2.09B in cash and marketable securities with HK$4.72B in debt, giving a net cash position of -HK$2.63B billion.
Cash & Marketable SecuritiesHK$2.09B
Total DebtHK$4.72B
Net Cash-HK$2.63B
Net Cash Per Share-HK$0.74
Tangible Book Value Per ShareHK$3.49
Margins
Gross margin is 55.20%, with operating margin of 12.58%, and net profit margin of 10.10%.
Gross Margin55.20%
Operating Margin12.58%
Pretax Margin12.16%
Net Profit Margin10.10%
EBITDA Margin17.32%
EBIT Margin12.58%
Analyst Forecast
The average price target for Grand Pharmaceutical Group Limited is HK$12.00, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price TargetHK$12.00
Price Target Upside53.85% Upside
Analyst ConsensusModerate Buy
Analyst Count1
Revenue Growth Forecast5.48%
EPS Growth Forecast-49.67%